Hepatic phenotype of liver fatty acid binding protein gene-ablated mice
- 1 December 2009
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 297 (6), G1053-G1065
- https://doi.org/10.1152/ajpgi.00116.2009
Abstract
Although the function of liver fatty acid binding protein in hepatic fatty acid metabolism has been extensively studied, its potential role in hepatic cholesterol homeostasis is less clear. Although hepatic cholesterol accumulation was initially reported in L-FABP-null female mice, that study was performed with early N2 backcross generation mice. To resolve whether the hepatic cholesterol phenotype in these L-FABP−/−mice was attributable to genetic inhomogeneity, these L-FABP−/−mice were further backcrossed to C57Bl/6 mice up to the N10 (99.9% homogeneity) generation. Hepatic total cholesterol accumulation was observed in female, but not male, L-FABP−/−mice at all (N2, N4, N6, N10) backcross generations examined. The greater total cholesterol was due to increased hepatic levels of both unesterified (free) cholesterol and esterified cholesterol. Altered hepatic cholesterol accumulation correlated directly with L-FABP's ability to bind cholesterol with high affinity as shown by direct L-FABP binding of fluorescent cholesterol analogs (NBD-cholesterol, dansyl-cholesterol), a photoactivatable cholesterol analog [free cholesterol benzophenone (FCBP)], and free cholesterol (circular dichroism, isothermal titration microcalorimetry). One mole of fluorescent sterol was bound per mole of L-FABP. This was confirmed by photo-cross-linking studies with the photoactivatable cholesterol analog FCBP and by isothermal titration calorimetry with free cholesterol, which showed that L-FABP bound only one sterol molecule per L-FABP molecule. In contrast, the hepatic phenotype of male, but not female, L-FABP−/−mice was characterized by decreased hepatic triacylglycerol levels at all backcross generations examined. Taken together, these data support the hypothesis that L-FABP plays a role in physiological regulation of not only hepatic fatty acid metabolism, but also that of hepatic cholesterol.Keywords
This publication has 104 references indexed in Scilit:
- Liver type fatty acid binding protein (L-FABP) gene ablation reduces nuclear ligand distribution and peroxisome proliferator-activated receptor-α activity in cultured primary hepatocytesArchives of Biochemistry and Biophysics, 2009
- Green fluorescent proteins are light-induced electron donorsNature Chemical Biology, 2009
- Diet-induced alterations in intestinal and extrahepatic lipid metabolism in liver fatty acid binding protein knockout miceMolecular and Cellular Biochemistry, 2008
- Liver fatty acid binding protein gene ablation enhances age-dependent weight gain in male miceMolecular and Cellular Biochemistry, 2008
- Altered hepatic triglyceride content after partial hepatectomy without impaired liver regeneration in multiple murine genetic models†Hepatology, 2008
- Structure and Function of the Sterol Carrier Protein-2 N-Terminal PresequenceBiochemistry, 2008
- Structural Basis for Activation of Fatty Acid-binding Protein 4Journal of Molecular Biology, 2007
- A New N-Terminal Recognition Domain in Caveolin-1 Interacts with Sterol Carrier Protein-2 (SCP-2)Biochemistry, 2007
- Very-Long-Chain and Branched-Chain Fatty Acyl-CoAs Are High Affinity Ligands for the Peroxisome Proliferator-Activated Receptor α (PPARα)Biochemistry, 2006
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976